CS2-02 Streptococcus suis Infections in Humans

Streptococcus suis in Humans, Thailand

ing which time the surgeon suspended surgical procedures. Recommendations were made regarding infection prevention practices; these were undertaken by the surgeon. Although soft tissue infection following sclerotherapy may be underreported, large case series have not noted this complication in the past (2,3); this fi nding suggests that any soft tissue infection following sclerotherapy should b...

Streptococcus suis infections in humans: the Chinese experience and the situation in North America.

Infections caused by Streptococcus suis are considered a global problem in the swine industry. In this animal species, S. suis is associated with septicemia, meningitis, endocarditis, arthritis and, occasionally, other infections. Moreover, it is an agent of zoonosis that afflicts people in close contact with infected pigs or pork-derived products. Although sporadic cases of S. suis infection i...

Novel Streptococcus suis Sequence Type 834 among Humans, Madagascar

Two cases of meningitis caused by Streptococcus suis occurred in Madagascar, 1 in 2015 and 1 in 2016. We report the characterization of the novel sequence type, 834, which carried the mrp+/sly+/epf+ virulence marker and a mutation G→T at position 174, leading to a substitution mutS1 to mutS284.

Porcine Streptococcus suis strains as potential sources of infections in humans: an underdiagnosed problem in North America?

S treptococcus suis is a gram-positive coccus, possessing cell wall antigenic determinants related to Lancefield group D, although it is genetically unrelated to other members of this group, such as enterococci. Streptococcus suis is a capsulated bacterium, with the composition of the capsule defining the serotype. There are presently 35 capsular types or serotypes. The original classification ...

Streptococcus suis infection